The Human Microbiome and Cancer: New Opportunities For Population Studies | Emily Vogtmann, PhD, MPH

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

The NIH’s human microbiome project | Lita Proctor, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Live Biotherapeutics: How the Vaginal Microbiome Can be Modified to Prevent HIV Infection | Laurel Lagenaur, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Functional Role of Gut Microbiota in Chronic Liver Disease | Gary Wu, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Key note: Systems Biology, Modeling, and Cross-Meta-Omic Analysis of the Human Microbiome | Elhanan Borenstein, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Zika Neuropathies Beyond Microcephaly | Maurício Lacerda Nogueira, MD, PhD

HIV DART and Emerging Viruses 2016

Global Burden and Novel Treatment of Noroviruses | Ladislau Kovari, PhD

HIV DART and Emerging Viruses 2016

State of the Art Lecture: What Do We Really Know About Dengue Viruses | Oscar Perng, PhD

HIV DART and Emerging Viruses 2016

HIV Knowledge and Hope in Africa | Carol A. Harris, MD

HIV DART and Emerging Viruses 2016

Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH

HIV DART and Emerging Viruses 2016

Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD

HIV DART and Emerging Viruses 2016

Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD

HIV DART and Emerging Viruses 2016

HIV-1 Macrophage Reservoirs: Lessons from Host Macrophage Specific Restriction Factor, SAMHD1 | Baek Kim, PhD

HIV DART and Emerging Viruses 2016

David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD

HIV DART and Emerging Viruses 2016

Presentation of David Barry DART Achievement Award | Raymond Schinazi, PhD, DSc

HIV DART and Emerging Viruses 2016

Russian HIV Clinical Series | Anna Maria Geretti | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Russian HIV Clinical Series | Roger Paredes | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Russian HIV Clinical Series | Natalia Litvinova | 2nd Edition | 15 April

Russian HIV Clinical Series 2021

Update on DDI guidelines of the FDA - in vitro | Xinning Yang, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&H

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

How/when will pharmacogenomics translate into improved clinical care? | David Haas, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBA

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

The use of DAA’s in pregnancy in HCV infected mothers | David Burger, PharmD, PhD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018